| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |